BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 808204)

  • 1. Survival after regional perfusion for limb melanoma.
    Cox KR
    Aust N Z J Surg; 1975 Feb; 45(1):32-6. PubMed ID: 808204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional chemotherapy for melanoma. A 35-year experience.
    Krementz ET; Carter RD; Sutherland CM; Muchmore JH; Ryan RF; Creech O
    Ann Surg; 1994 Oct; 220(4):520-34; discussion 534-5. PubMed ID: 7944662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective therapy: repeat limb perfusion for recurrent melanoma.
    Krementz ET
    J Am Coll Surg; 1996 Jun; 182(6):547-8. PubMed ID: 8646356
    [No Abstract]   [Full Text] [Related]  

  • 4. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
    Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
    J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfusion of melanoma. 105 isolated perfusions in 92 patients.
    Golomb FM
    Oncology; 1972; 26(2):197-205. PubMed ID: 4626136
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylactic isolation-perfusion as the primary therapy for invasive malignant melanoma of the limbs.
    McBride CM; Sugarbaker EV; Hickey RC
    Ann Surg; 1975 Sep; 182(3):316-24. PubMed ID: 1164059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation perfusion. An adjunct to surgical excision in the primary treatment of melanoma of the extremities.
    Alrich EM; Manwaring JL; Horsley JS
    Am J Surg; 1971 May; 121(5):583-5. PubMed ID: 5557770
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy of melanoma of the extremities by perfusion: fourteen years clinical experience.
    Krementz ET; Ryan RF
    Ann Surg; 1972 Jun; 175(6):900-17. PubMed ID: 4625027
    [No Abstract]   [Full Text] [Related]  

  • 9. Regional isolated perfusion of extremities for melanoma: a 20-year experience with drugs other than L-phenylalanine mustard.
    Ariyan S; Poo WJ; Bolognia J
    Plast Reconstr Surg; 1997 Apr; 99(4):1023-9. PubMed ID: 9091898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxic pelvic and limb perfusion with melphalan and mitomycin C for recurrent limb melanoma: a pilot study.
    Guadagni S; Santinami M; Patuzzo R; Pilati PL; Miotto D; Deraco M; Rossi CR; Fiorentini G; Di Filippo F; Valenti M; Amicucci G
    Melanoma Res; 2003 Feb; 13(1):51-8. PubMed ID: 12569285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated limb perfusion with melphalan in the treatment of malignant melanoma.
    Bulman AS; Jamieson CW
    Br J Surg; 1980 Sep; 67(9):660-2. PubMed ID: 7427069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases.
    Deroose JP; Grünhagen DJ; van Geel AN; de Wilt JH; Eggermont AM; Verhoef C
    Br J Surg; 2011 Nov; 98(11):1573-80. PubMed ID: 21739427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regional chemotherapy--perfusion of the extremities].
    Meyer T; Göhl J
    Kongressbd Dtsch Ges Chir Kongr; 2001; 118():200-4. PubMed ID: 11824246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfusion of melanoma. 133 isolated perfusions in 114 patients.
    Golomb FM
    Panminerva Med; 1976; 18(1-2):8-10. PubMed ID: 813172
    [No Abstract]   [Full Text] [Related]  

  • 15. Survival and regional disease control after isolation-perfusion for invasive stage I melanoma of the extremities.
    Sugarbaker EV; McBride CM
    Cancer; 1976 Jan; 37(1):188-98. PubMed ID: 1247954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of regional perfusion treatment on recurrent melanoma of the extremities.
    Hansson JA; Simert G; Vang J
    Acta Chir Scand; 1977; 143(1):33-9. PubMed ID: 855620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant regional isolated perfusion with melphalan for patients with Clark V melanoma of the extremities.
    Vrouenraets BC; Kroon BB; Klaase JM; Van Geel BN; Eggermont AM; Franklin HR
    J Surg Oncol; 1993 Apr; 52(4):249-54. PubMed ID: 8468989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated limb perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs.
    Thompson JF; Gianoutsos MP
    World J Surg; 1992; 16(2):227-33. PubMed ID: 1561803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant regional isolation perfusion of the extremities of patients with stage I melanoma thicker than 1.5 mm].
    Kroon BB; Schraffordt Koops H
    Ned Tijdschr Geneeskd; 1990 Oct; 134(42):2042-7. PubMed ID: 2234177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative evaluation of treatment results of melanoblastoma of the limbs with or without perfusion chemotherapy].
    Levin AO; Stepanova NS; Chikinda IuN
    Vestn Khir Im I I Grek; 1979 Feb; 122(2):53-6. PubMed ID: 108833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.